Castleview Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$667K Sell
4,548
-219
-5% -$39.7K 0.29% 80
2026
Q1
$701K Sell
4,767
-1,361
-22% -$221K 0.36% 66
2025
Q4
$1.19M Buy
6,128
+134
+2% +$31.9K 0.59% 39
2025
Q3
$1.69M Sell
5,994
-796
-12% -$203K 0.92% 26
2025
Q2
$1.48M Sell
6,790
-47
-0.7% -$7.59K 0.95% 24
2025
Q1
$956K Buy
6,837
+1,090
+19% +$177K 0.65% 36
2024
Q4
$954K Buy
5,747
+702
+14% +$125K 0.51% 46
2024
Q3
$860K Buy
5,045
+3,183
+171% +$461K 0.5% 45
2024
Q2
$263K Buy
1,862
+1,376
+283% +$171K 0.15% 140
2024
Q1
$61K Hold
486
0.03% 328
2023
Q4
$51.2K Hold
486
0.04% 290
2023
Q3
$51.5K Hold
486
0.05% 249
2023
Q2
$57.9K Hold
486
0.05% 239
2023
Q1
$45.2K Hold
486
0.04% 276
2022
Q4
$39.7K Hold
486
0.04% 252
2022
Q3
$30K Sell
486
-514
-51% -$37.6K 0.03% 298
2022
Q2
$917 Buy
1,000
+414
+71% +$30.3K ﹤0.01% 696
2022
Q1
$48K Sell
586
-53,571
-99% -$4.34M 0.03% 354
2021
Q4
$621 Buy
+54,157
New +$5.08M 0.01% 477
2021
Q2
$64K Buy
+821
New +$64.3K 0.03% 359

Other funds holding ORCL

Castleview Partners's ORCL Position: Q2 2026 in Review

Castleview Partners reduced its Oracle (ORCL) stake by 4.6% in Q2 2026, selling an estimated $39.7K and leaving 4,548 shares worth $667K. The position accounts for 0.29% of the portfolio, ranked #80.

Castleview Partners first reported a position in ORCL in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.69M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Castleview Partners held 4,548 shares of Oracle worth $667K as of Q2 2026.
  • Castleview Partners sold 219 Oracle shares in Q2 2026, an estimated $39.7K.
  • Oracle made up 0.29% of Castleview Partners's portfolio in Q2 2026, its #80 holding.
  • Castleview Partners first reported a position in Oracle in Q2 2021 and has held it in 20 quarters since.
  • Castleview Partners's Oracle position peaked at $1.69M in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.